JESSE COALE: Open Payments
NPI 1629130216 · SPRINGFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 58 payments from 21 companies in 2025. Trend: 2023 $3,501 · 2024 $3,022 · 2025 $1,646
Food & beverage: $1,646
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $286 |
| AstraZeneca Pharmaceuticals LP | 6 | $218 |
| Otsuka America Pharmaceutical, Inc. | 5 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $181 |
| Insulet Corporation | 2 | $136 |
| SHIELD THERAPEUTICS INC | 2 | $86 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| PFIZER INC. | 4 | $78 |
| ABBVIE INC. | 3 | $60 |
| Abbott Laboratories | 2 | $47 |
Products named: Kerendia, REXULTI, CAPLYTA, Omnipod, BREZTRI, ACCRUFER, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
